The markets roiled and recent IPOs took a nosedive, but four deals managed to raise $1.0 billion this week. Software unicorn Anaplan (PLAN) and cancer biotech Allogene (ALLO) popped over 40%. Two others ended at or...read more
Livent, a lithium compound producer being spun out of FMC, raised $340 million by offering 20 million shares at $17, below the range of $18 to $20. Livent plans to list on the NYSE under the symbol LTHM. BofA Merrill Lynch, Goldman Sachs and Credit Suisse...read more
ThiS 5-IPO week is led by cloud-based business planning software provider Anaplan, which hopes to follow in the footsteps of the many other high-flying SaaS IPOs of 2018 (31% average return). Also pricing this week is Livent, which produces lithium...read more
October's winners & losers: Growth IPOs still flying high
Despite the market sell-off, the October IPO market was relatively active with 22 deals, and ...read more
US IPO Weekly Recap: Despite sell-off, 4 IPOs price with unicorn Anaplan up 43%
The markets roiled and recent IPOs took a nosedive, but four deals managed to raise $1.0 billion this week. Software unicorn Anaplan (PLAN) and cancer biotech Allogene (ALLO) popped over 40%. Two others ended at or...read more
Livent prices IPO at $17, below the range
Livent, a lithium compound producer being spun out of FMC, raised $340 million by offering 20 million shares at $17, below the range of $18 to $20. Livent plans to list on the NYSE under the symbol LTHM. BofA Merrill Lynch, Goldman Sachs and Credit Suisse...read more
US IPO Week Ahead: Anaplan leads this upcoming 5-IPO week
ThiS 5-IPO week is led by cloud-based business planning software provider Anaplan, which hopes to follow in the footsteps of the many other high-flying SaaS IPOs of 2018 (31% average return). Also pricing this week is Livent, which produces lithium...read more